BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Press Releases

  Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - September 29, 2026

  September 29, 2026

   · 

  2 min read
• Press Releases

  Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - September 29, 2026

  September 29, 2026

   · 

  3 min read
• Press Releases

  Cuprina Holdings (Cayman) Limited Announces Closing of Underwriter’s Over-Allotment Option in Connection with Public Offering

  September 29, 2026

   · 

  4 min read
• Press Releases

  TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP

  September 29, 2026

   · 

  4 min read
• Press Releases

  IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026

  September 29, 2026

   · 

  2 min read
• Press Releases

  CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026

  September 29, 2026

   · 

  4 min read
• Press Releases

  Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders

  September 29, 2026

   · 

  6 min read
• Press Releases

  Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology

  September 29, 2026

   · 

  5 min read
• Press Releases

  DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

  September 29, 2026

   · 

  6 min read
• Press Releases

  Lilly’s triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes

  September 29, 2026

   · 

  22 min read